Entyvio 64764-0107-11
Generic: Vedolizumab
- Manufacturer
- Takeda Pharmaceuticals America, Inc.
- Dosage Form
- Injection, Solution
- Route
- Subcutaneous
- Product Type
- Human Prescription Drug
- Marketing Start
- September 27, 2023
- Listing Expires
- December 31, 2027
- Application
- BLA761133
Need to source Entyvio? Find it on a pharmacy-to-pharmacy marketplace at better prices.
✓ DSCSA Compliant. ✓ Verified Pharmacies Only.P2P pharmacy marketplace.
Active Ingredients
| Ingredient | Strength |
|---|---|
| Vedolizumab | 108 mg/.68mL |
Drug Class
Integrin Receptor Antagonist [EPC]Integrin Receptor Antagonist [EPC]Integrin Receptor Antagonists [MoA]
Selected Package
64764-0107-11Selected1 TRAY in 1 CARTON (64764-107-11) / 1 SYRINGE in 1 TRAY (64764-107-10) / .68 mL in 1 SYRINGE